‘Future Is Bright’ With Bispecifics for Relapsed/Refractory Myeloma
June 3rd 2023An expert from Vanderbilt University Medical Center says that patients with relapsed/refractory multiple myeloma may be able to live a normal life following response to salvage treatment with bispecific monoclonal antibodies.